1.6  0.1 (6.67%)		04-26 15:59
Open: 1.4899 High: 1.78 Volume: 26,703		Pre. Close: 1.5 Low: 1.4799 Market Cap: 9(M)

Short term
Mid term
Targets	6-month :	2.57	1-year :	3.29
Resists	First :	2.2	Second :	2.81
Pivot price	1.73
Supports	First :	1.21	Second :	1
MAs	MA(5) :	1.52	MA(20) :	1.89
	MA(100) :	0	MA(250) :	0
MACD	MACD :	-0.4	Signal :	-0.5
%K %D	K(14,3) :	27.4	D(3) :	24.5
RSI	RSI(14): 36.7
52-week	High :	4.84	Low :	1.21

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CHRO ] has closed above bottom band by 37.2%. Bollinger Bands are 0% narrower than normal.

If tomorrow:	Open lower	Open higher
High:	1.78 - 1.79	1.79 - 1.8
Low:	1.46 - 1.47	1.47 - 1.48
Close:	1.59 - 1.6	1.6 - 1.61

Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.

Fri, 19 Apr 2024
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's - Benzinga

Fri, 19 Apr 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session - Chromocell Therapeutics (AMEX:CHRO), Erasca - Benzinga

Wed, 17 Apr 2024
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket - Markets Insider

Wed, 17 Apr 2024
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket - INVO B - Benzinga

Wed, 17 Apr 2024
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day ... - Markets Insider

Mon, 19 Feb 2024
Opening Day: Chromocell Therapeutics, Unusual Machines make public debut - TipRanks.com - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.